Related Experiment Video

Updated: May 31, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

MRSA infections in children

R C Sanders, R M Diokno, J Romero

    The Journal of the Arkansas Medical Society
    |June 30, 2011
    PubMed

    Insights

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a growing global health threat, increasingly seen in both hospital and community settings. Understanding MRSA transmission and spread is crucial for effective control and management strategies.

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Public Health

    Background:

    • Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant and escalating challenge to healthcare systems worldwide.
    • Historically confined to hospital settings, MRSA is now prevalent in the outpatient environment, indicating a shift in transmission dynamics.
    • The increasing prevalence necessitates a comprehensive understanding of MRSA's distribution patterns and contributing factors.

    Purpose of the Study:

    • To review the current state of Methicillin-resistant Staphylococcus aureus (MRSA) transmission.
    • To identify and analyze factors associated with the widespread distribution of MRSA.
    • To provide insights into effective control and management strategies for MRSA infections.

    Main Methods:

    • Literature review of current research on MRSA.
    • Analysis of epidemiological data on MRSA prevalence and distribution.
    • Synthesis of information on MRSA transmission, control, and management.

    Main Results:

    • MRSA infections are a formidable and exponentially increasing challenge for healthcare providers.
    • MRSA is now encountered in outpatient settings, not just among hospitalized patients.
    • Understanding MRSA distribution and spread factors is paramount for recognition and eradication.

    Conclusions:

    • Effective recognition and eradication of MRSA require a thorough understanding of its widespread distribution.
    • Current MRSA transmission, control, and management strategies need continuous review and adaptation.
    • Addressing the evolving landscape of MRSA necessitates a multi-faceted approach encompassing surveillance and intervention.

    Related Concept Videos

    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
    Staphylococcal Skin Infections01:29

    Staphylococcal Skin Infections

    Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Rocky Mountain Spotted Fever01:26

    Rocky Mountain Spotted Fever

    Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...